Johnson & Johnson at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Johnson & Johnson brings 1 presentation to AMP 2026 in Seattle, and exhibits at Booth 817. Its session covers biomarker discovery and selection across genitourinary cancers and the part pathology plays in that pathway. The company's medicines span oncology, immunology, neuroscience and cardiovascular disease.

OrganizationAMP 2026 Attendance
Johnson & Johnson
New Brunswick, NJ
jnj.com
BiopharmaPlatinum Partner
Johnson & Johnson Innovative Medicine develops medicines in oncology, immunology, neuroscience, cardiovascular disease, pulmonary hypertension and retina.
Booth
Exhibiting at Booth 817
Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm
🏅Platinum Partner
Workshop
Wed, Nov 11
8:00am–8:50am
The Precision Pathway: How Pathologists Are Transforming Biomarker Discovery, Selection, and Clinical Impact Across GU Cancers
Biomarker selection, specimen handling and reporting for genitourinary cancers, worked through interactive case discussions.
Skagit 2, Lower Level, Arch at 800 Pike

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Johnson & Johnson

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction